Citadel Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.2M Buy
1,493,446
+1,040,487
+230% +$53M 0.01% 999
2025
Q4
$22.5M Sell
452,959
-963,967
-68% -$46.9M ﹤0.01% 2209
2025
Q3
$67.7M Buy
1,416,926
+1,241,792
+709% +$50M 0.01% 1116
2025
Q2
$5.52M Buy
175,134
+13,620
+8% +$436K ﹤0.01% 3933
2025
Q1
$5.29M Buy
161,514
+67,074
+71% +$2.38M ﹤0.01% 3772
2024
Q4
$3.41M Sell
94,440
-9,812
-9% -$346K ﹤0.01% 4620
2024
Q3
$3.25M Sell
104,252
-38,680
-27% -$1.21M ﹤0.01% 4651
2024
Q2
$3.82M Buy
142,932
+55,638
+64% +$1.61M ﹤0.01% 4177
2024
Q1
$2.98M Sell
87,294
-122,827
-58% -$3.66M ﹤0.01% 4805
2023
Q4
$6.08M Sell
210,121
-165,705
-44% -$4.39M ﹤0.01% 3532
2023
Q3
$10.4M Buy
375,826
+286,839
+322% +$8.73M ﹤0.01% 2648
2023
Q2
$2.67M Sell
88,987
-15,167
-15% -$531K ﹤0.01% 4655
2023
Q1
$3.77M Sell
104,154
-289,681
-74% -$11.1M ﹤0.01% 4275
2022
Q4
$14M Buy
393,835
+84,144
+27% +$2.92M ﹤0.01% 2381
2022
Q3
$10.5M Buy
309,691
+216,771
+233% +$7.05M ﹤0.01% 2690
2022
Q2
$2.69M Sell
92,920
-13,341
-13% -$382K ﹤0.01% 4962
2022
Q1
$3.43M Sell
106,261
-854
-0.8% -$26.2K ﹤0.01% 4904
2021
Q4
$3.12M Buy
107,115
+91,880
+603% +$2.79M ﹤0.01% 5257
2021
Q3
$406K Sell
15,235
-389,288
-96% -$10.4M ﹤0.01% 10375
2021
Q2
$12.5M Buy
404,523
+352,367
+676% +$10.8M ﹤0.01% 2744
2021
Q1
$1.36M Buy
52,156
+37,080
+246% +$1.04M ﹤0.01% 7346
2020
Q4
$379K Buy
+15,076
New +$324K ﹤0.01% 8663
2020
Q2
Sell
-713,240
Closed -$15.8M 10475
2020
Q1
$12.8M Buy
713,240
+432,084
+154% +$9.08M 0.01% 1626
2019
Q4
$6.67M Buy
281,156
+52,236
+23% +$1.27M ﹤0.01% 2711
2019
Q3
$6.29M Buy
228,920
+94,365
+70% +$2.8M ﹤0.01% 2789
2019
Q2
$4.45M Sell
134,555
-12,083
-8% -$414K ﹤0.01% 3267
2019
Q1
$5.14M Buy
146,638
+71,646
+96% +$2.67M ﹤0.01% 2964
2018
Q4
$2.49M Buy
74,992
+29,128
+64% +$1.25M ﹤0.01% 3809
2018
Q3
$2.31M Sell
45,864
-29,610
-39% -$1.46M ﹤0.01% 4172
2018
Q2
$4.52M Sell
75,474
-138,170
-65% -$7.16M ﹤0.01% 2901
2018
Q1
$9.79M Buy
213,644
+201,204
+1,617% +$8.4M 0.01% 1764
2017
Q4
$496K Sell
12,440
-61,463
-83% -$2.43M ﹤0.01% 5658
2017
Q3
$2.96M Buy
73,903
+29,112
+65% +$1.26M ﹤0.01% 2941
2017
Q2
$1.93M Buy
+44,791
New +$1.59M ﹤0.01% 3211
2017
Q1
Sell
-40,122
Closed -$1.08M 8021
2016
Q4
$1.01M Buy
+40,122
New +$896K ﹤0.01% 3832
2016
Q2
Sell
-39,112
Closed -$694K 7380
2016
Q1
$596K Sell
39,112
-276,899
-88% -$3.61M ﹤0.01% 4160
2015
Q4
$4.25M Buy
316,011
+300,161
+1,894% +$4.64M ﹤0.01% 1959
2015
Q3
$222K Sell
15,850
-143,114
-90% -$2.66M ﹤0.01% 6009
2015
Q2
$2.7M Sell
158,964
-31,440
-17% -$447K ﹤0.01% 2704
2015
Q1
$2.3M Sell
190,404
-73,312
-28% -$693K ﹤0.01% 2893
2014
Q4
$2.19M Buy
263,716
+68,770
+35% +$578K ﹤0.01% 2811
2014
Q3
$1.69M Buy
194,946
+161,147
+477% +$1.46M ﹤0.01% 3046
2014
Q2
$370K Sell
33,799
-46,127
-58% -$411K ﹤0.01% 4777
2014
Q1
$715K Buy
79,926
+64,997
+435% +$599K ﹤0.01% 3856
2013
Q4
$113K Buy
+14,929
New +$104K ﹤0.01% 5513
2013
Q3
Sell
-8,365
Closed -$56.2K 6860
2013
Q2
$54K Buy
+8,365
New +$49.3K ﹤0.01% 5623

Other funds holding SUPN